Patellofemoral Pain Syndrome Terminated Phase 3 Trials for Botulinum toxin type A (DB00083)

Also known as: Patellofemoral pain syndrome / Anterior Knee Pain Syndrome / Pain Syndrome, Patellofemoral

IndicationStatusPhase
DBCOND0002151 (Patellofemoral Pain Syndrome)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00496964Botox for Non-surgical Lateral Release in Patellofemoral PainTreatment